Manuela Battaglia

PyArchinit: Database Mangement System and Archaeological GIS

Enzo Cocca, Luca Mandolesi, Simona Gugnali, 2011 .

Understanding and preventing type 1 diabetes through the unique working model of TrialNet

Mark S. Anderson, Mark Peakman, Manuela Battaglia, 2017, Diabetologia.

Loss of immune tolerance to IL-2 in type 1 diabetes

Olivier Boyer, Roberto Mallone, John M. Lindner, 2016, Nature Communications.

Hurdles in therapy with regulatory T cells

Andrew Bushell, Anja ten Brinke, Giovanna Lombardi, 2015, Science Translational Medicine.

Human CD25+CD4+ T Suppressor Cell Clones Produce Transforming Growth Factor β, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells

Manuela Battaglia, Megan K. Levings, M. Battaglia, 2002, The Journal of experimental medicine.

Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes.

Peter S. Linsley, Sarah J. Richardson, Francesco Dotta, 2018, JCI insight.

Erratum to: Understanding and preventing type 1 diabetes through the unique working model of TrialNet

Mark S. Anderson, Bart O. Roep, Carla J. Greenbaum, 2017, Diabetologia.

Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412.

Hermann Einsele, Manuela Battaglia, H. Einsele, 2011, Blood.

Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans

Katharina Fleischhauer, Rosa Bacchetta, Manuela Battaglia, 2006, Immunological reviews.